July 2020 Extra Articles
Chiasma Gets Approval for Oral Acromegaly Medication
The F.D.A. has given approval to Chiasma Inc for its MYCAPSSA (octreotide) capsules, which are used for long-term maintenance treatment in acromegalics. This is a first, and will allow patients with chronic acromegaly to avoid painful injections. It is projected to be available by the end of the year.
Read more: https://en.globes.co.il/en/article-chiasma-wins-fda-approval-for-acromegaly-treatment-1001333990
FDA Letter: https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208232Orig1s000ltr.pdf
Sri Lanka Scientists Claim COVID May Cause Endocrine Disease
An article on thehealthsite.com looks at whether the novel coronavirus affects the endocrine system, and whether pituitary patients are more vulnerable to adrenal insufficiency, diabetes and thyroid disorders. Read more:
Patient story: Irregular Period Was First Sign of the Tumor
Lauren Topor, a pituitary patient in her twenties from Arizona, tells her story to Women’s Health magazine. Topor discovered she had a brain tumor after several months of irregular periods. Her advice? Listen to your body and get the care you need. Read more:
Photo curtesy Lauren Topor
Can Stress Make You Less Productive?
An article in Fast Company looks at the effects of long-term low-grade stress on people’s ability to get things done. The author cites studies that show that paying attention to the body’s signals and meditating can help. Read more: